DaVita (DVA) vs peers
DVA's EV/Sales is 1.6x, compared with 1.3x at the middle of 4 peers.
Health Care Services. Updated .
| Stock | EV/Sales | Own 5-year rank |
|---|---|---|
| DVADaVita | 1.6x | 49% |
| DGXQuest Diagnostics | 2.8x | 99% |
| LHLabcorp | 2.3x | 96% |
| CVSCVS Health | 0.4x | 54% |
| CICigna | 0.4x | 14% |
How to read this comparison
Up to eight covered companies in the same industry, largest market value first.
EV/Sales divides enterprise value (stock market value plus debt, less cash) by revenue from the previous twelve months. The middle peer reading excludes DVA and unavailable values.
Own 5-year rank compares each stock with its available weekly readings within the last five years. At least 26 usable weeks are required. A rank of 20% means its current multiple is above 20% of its past readings. It is not a rank against the other stocks in this table.
Dates show data updates; the latest available weekly observation can differ between stocks. Different growth rates, margins and financial risks can explain different multiples. Missing or non-positive denominators are left unranked.